07/31/2025
10:33 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/31/2025
7:06 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/31/2025
6:34 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/30/2025
7:09 AM | Sanofi (Filer)
Sanofi (Filer)
| Form N-PX
Annual Report of Proxy Voting Record of Registered Management Investment Company | |
07/29/2025
11:18 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers | |
07/22/2025
7:49 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/18/2025
5:03 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/17/2025
5:04 AM | Blueprint Medicines Corp (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
| Form SC TO-T/A | |
07/10/2025
5:04 AM | Blueprint Medicines Corp (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
| Form SC TO-T/A | |
07/02/2025
7:25 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/27/2025
3:49 PM | Sanofi (Filer)
Sanofi (Filer)
| Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
Get the Latest News and Ratings for SNYNF and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Sanofi and its competitors with MarketBeat's FREE daily newsletter. |
06/24/2025
7:31 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/18/2025
5:43 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/17/2025
7:33 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/17/2025
5:07 AM | Blueprint Medicines Corp (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
| Form SC TO-T | |
06/06/2025
10:35 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/02/2025
4:11 PM | Blueprint Medicines Corp (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
| Form SC TO-C | |
06/02/2025
5:09 AM | Blueprint Medicines Corp (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
| Form SC TO-C | |
06/02/2025
5:07 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/30/2025
9:51 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/22/2025
7:09 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/21/2025
9:55 AM | Sanofi (Filer)
Sanofi (Filer)
| Form SD
Specialized Disclosure Report | |
05/12/2025
3:50 PM | Amundi (Filed by)
Sanofi (Subject)
Sanofi (Subject)
| Form SCHEDULE 13G/A | |
05/06/2025
5:15 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers | |
05/05/2025
12:12 PM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/30/2025
1:50 PM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2025
5:48 PM | Innate Pharma SA (Subject)
Innate Pharma SA (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
| Form SCHEDULE 13G/A | |
04/24/2025
9:13 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/23/2025
6:39 PM | BlackRock, Inc. (Filed by)
Sanofi (Subject)
Sanofi (Subject)
| Form SCHEDULE 13G/A | |
04/22/2025
11:29 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/16/2025
8:18 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/10/2025
5:11 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/04/2025
7:43 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/02/2025
5:15 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/27/2025
12:39 PM | Sanofi (Filer)
Sanofi (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/26/2025
10:56 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/21/2025
5:04 AM | Sanofi (Filer)
Sanofi (Filer)
| Form S-8 POS | |
03/20/2025
10:06 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/10/2025
11:23 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/06/2025
9:24 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/28/2025
5:14 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Buffett to put 90% of his money in this one stock? (Ad) CPA and CFA says you have WAY too many stocks - just buy these 3
After years working at the biggest accounting firms like Deloitte and KPMG, Joel Litman (who’s also a member of the Global CFA Institute) figured out a unique, less-risky way to grow rich in the stock market. Litman says you don’t need dozens of investments, overpriced advisers, or hedge funds. You just need these 3 stocks, which have helped Litman’s own mom earn 3,400%. Click here to view… |
02/20/2025
11:18 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2025
11:14 AM | Amundi (Filed by)
Sanofi (Subject)
Sanofi (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025
10:28 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 13F-HR
Initial Quarterly Form 13F Holdings report filed by institutional managers | |
02/13/2025
1:11 PM | Sanofi (Filer)
Sanofi (Filer)
| Form IRANNOTICE | |
02/13/2025
12:41 PM | Sanofi (Filer)
Sanofi (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
02/13/2025
11:23 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/07/2025
10:14 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/03/2025
11:14 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/30/2025
8:50 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/24/2025
5:04 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/14/2025
7:40 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/23/2024
1:08 PM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/20/2024
5:07 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/13/2024
10:07 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/18/2024
11:23 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/07/2024
1:49 PM | Amundi (Filed by)
Sanofi (Subject)
Sanofi (Subject)
| Form SC 13G/A | |
11/07/2024
10:35 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/31/2024
5:56 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/25/2024
11:39 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/21/2024
10:47 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/11/2024
2:35 PM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/02/2024
10:06 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/24/2024
1:51 PM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/13/2024
11:46 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/03/2024
9:46 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/13/2024
8:06 AM | MeiraGTx Holdings plc (Subject)
Sanofi (Filed by)
Sanofi (Filed by)
| Form SC 13G/A | |
08/13/2024
5:30 AM | MeiraGTx Holdings plc (Issuer)
Sanofi (Reporting)
Sanofi (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/13/2024
5:05 AM | Sanofi (Filer)
Sanofi (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
